These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2348559)

  • 1. [A histological evaluation of the therapeutic effects and the clinical findings in prostatic carcinomas].
    Koike H; Ishikura K; Fujioka T; Kubo T; Fujie T; Tamura G
    Gan No Rinsho; 1990 May; 36(6):715-8. PubMed ID: 2348559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on adenocarcinoma of the prostate].
    Mikata N; Imao S; Komatsu H
    Hinyokika Kiyo; 1993 Oct; 39(10):913-7. PubMed ID: 8266854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
    Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
    Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of prostatic cancer].
    Kudo K; Nagata M; Hayashi N; Imamura H; Iwamoto K; Kimura M; Matsubara M; Mimura H; Matsuyama K; Suwa J
    Hinyokika Kiyo; 1989 Aug; 35(8):1339-45. PubMed ID: 2816599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on adenocarcinoma of the prostate].
    Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
    Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
    Elfving P; Lundgren R
    Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the natural history on management of adenocarcinoma of the prostate].
    Schmid HP; Stamey TA; McNeal JE; Freiha FS; Redwine EA; Whittemore AS
    Urologe A; 1994 Mar; 33(2):144-8. PubMed ID: 7513916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
    Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
    Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thermochemotherapy of prostatic cancer].
    Hirai M
    Hinyokika Kiyo; 1991 Aug; 37(8):833-6. PubMed ID: 1720274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological study of 152 cases of prostatic cancer].
    Kondoh I; Miura T; Shimura H; Harada M; Fujii H
    Hinyokika Kiyo; 1992 Jun; 38(6):671-6. PubMed ID: 1632321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical investigation of prostate carcinoma in the Third Teaching Hospital of Norman Bethune University of Medical Sciences].
    Xiao LS; Niu FR; Xing GJ; Fu YW; Zhao LS; Liu ZY; Znang XP
    Hinyokika Kiyo; 1988 May; 34(5):814-8. PubMed ID: 3177123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y; Sakurai M; Hioki T; Hayashi N; Yamakawa K; Tajima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fast neutron radiotherapy of prostate cancer].
    Morita S; Tsunemoto H; Akimoto S; Fuse H; Shimazaki J; Fukushima G; Kitagawa R
    Gan No Rinsho; 1989 Feb; 35(3):378-84. PubMed ID: 2926986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of localized prostate cancer.
    Clarke NW
    Br J Hosp Med; 1996 Mar 6-19; 55(5):232-3. PubMed ID: 8777510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.